This NDC is on FDA's drug shortage list (posted Feb 15, 2023)
Product Information
ROCURONIUM 50 MG/5 ML VIAL is a generic product labeled by Piramal Critical Care, priced at $0.3942 per ML under NDC 66794022841. Its NADAC has been published 87 times since Jun 19, 2024.
FDA first approved this application on Aug 13, 2019. Its Orange Book therapeutic-equivalence code is AP.
Strength
50 mg/5mL
Manufacturer
Piramal Critical CareNDC
66794022841
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
4/22/2026
Active Ingredients
ROCURONIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210437FDA Approved
8/13/2019
TE Code
AP
On Market Since
7/20/2020
Pharmacological Classes
Price Statistics
The NADAC for ROCURONIUM 50 MG/5 ML VIAL has been published 87 times since Jun 19, 2024, and over the history we have for it it has declined 26.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3942 per ML |
|---|---|
| All-time high | $0.5377 (Oct 16, 2024) |
| All-time low | $0.3942 (Mar 18, 2026) |
| 52-week high | $0.5256 |
| 52-week low | $0.3942 |
| Median price | $0.5256 |
| Average price | $0.5145 |
| Largest weekly change | -25.0% (Mar 18, 2026) |
| Weeks tracked | 87 |
| Tracking since | Jun 19, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
-25.0%
3Y
N/A
5Y
N/A
All
-26.7%
Last surveyed May 13, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Rocuronium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Piramal Critical Care manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Rocuronium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nondepolarizing Neuromuscular Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROCURONIUM 50 MG/5 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ROCURONIUM 50 MG/5 ML VIAL, manufactured by Piramal Critical Care, is $0.3942 per ML (NDC 66794022841), effective May 13, 2026.
How has the price of ROCURONIUM 50 MG/5 ML VIAL changed over time?
Over the history we have for it, the NADAC for ROCURONIUM 50 MG/5 ML VIAL has declined 26.7%. It has been tracked across 87 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for ROCURONIUM 50 MG/5 ML VIAL?
Since Jun 19, 2024, the NADAC for ROCURONIUM 50 MG/5 ML VIAL has ranged from a low of $0.3942 (Mar 18, 2026) to a high of $0.5377 (Oct 16, 2024), with a median of $0.5256 per ML.
Are there cheaper alternatives to ROCURONIUM 50 MG/5 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of ROCURONIUM 50 MG/5 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ROCURONIUM 50 MG/5 ML VIAL?
ROCURONIUM 50 MG/5 ML VIAL (NDC 66794022841) is labeled by Piramal Critical Care, and CMS classifies it as a generic product.
Is ROCURONIUM 50 MG/5 ML VIAL in shortage?
Yes — NDC 66794022841 is currently listed in FDA's drug shortage database (posted Feb 15, 2023).